Rare diseases
Investigational molecules
Locations
15 Rue Andre Boquel, 49100 Angers, France
Comite Entreprise Paul Papin in Angers, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Squamous cell carcinoma of head and neck, Breast cancer metastatic, and other specialisations. This site conducts important research.
The Comite Entreprise Paul Papin in Angers focuses on Neoplasms, specifically studying non‑small cell lung cancer (NSCLC) with both squamous and nonsquamous histology. Researchers are evaluating new treatment combinations to improve patient outcomes.
With 76 investigators involved, the site’s patient‑centered approach aims to advance therapeutic options for advanced NSCLC after prior platinum‑based treatment.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FranceStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
FrancePhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
FranceStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
FranceStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
FranceDurvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
FranceA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
FranceEvaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer
FranceA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
